Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 549
Appendix G
Biographical Sketches of
Workshop Participants
Eric B. Bass, M.D., M.P.H., is a professor of medicine with joint appoint-
ments in the departments of epidemiology and health policy and manage-
ment at the Johns Hopkins University (JHU). He is the director of the JHU
Evidence-Based Practice Center, and codirector of the JHU Developing
Evidence to Inform Decisions about Effectiveness Center. He was the editor
of the Journal of General Internal Medicine for 5 years, and he is now the
editor-in-chief of Progress in Community Health Partnerships. He served
as the director of the general internal medicine fellowship at JHU for 15
years. He has extensive research experience in evidence-based medicine,
with special interests in assessment of the effectiveness and costs of medical
and surgical management strategies as well as in the assessment of patient
preferences. He also has expertise in curriculum development, having served
as a facilitator for the JHU Faculty Development Program and having coau-
thored a book on curriculum development. He has published more than
175 peer-reviewed articles as well as numerous evidence reports.
Lorne A. Becker, M.D., is emeritus professor at the State University of
New York (SUNY) Upstate Medical University in Syracuse, New York. He
serves as co-chair of the steering group of the Cochrane Collaboration, an
international nonprofit healthcare organization, and is also convenor of the
Cochrane Publishing Policy Group and Umbrella Reviews Working Group.
He served as chief of family medicine at the Toronto Hospital and, until
his retirement in 2004, he was chair of the Department of Family Medicine
at SUNY Upstate Medical University. Dr. Becker received his M.D. from
the University of Western Ontario, is a fellow of the American Academy
9
OCR for page 550
0 LEARNING WHAT WORKS
of Family Medicine and the College of Family Physicians of Canada, and
is a recipient of the Curtis Hames Research Award from the Society of
Teachers of Family Medicine. He is a member of the Research Commit-
tee of the World Organization of National Academies of Family Medicine
and of the Guidelines International Network Advisory Board. Previously
he has been a member of the board of the Society of Teachers of Family
Medicine, on the editorial boards of the Journal of Family Practice and of
Family Medicine (Oxford), and the coordinator of the Cochrane Primary
Health Care Field.
Rachel E. Behrman, M.D., M.P.H., is the associate commissioner for clini-
cal programs and director of the Office of Critical Path Programs of the
Food and Drug Administration (FDA). In that capacity, she is responsible
for developing, coordinating, and implementing policy and scientific pro-
grams aimed at innovating development and regulation of FDA-regulated
products. She also oversees the Good Clinical Practice Program, which
coordinates FDA policies on human subject protection and bioresearch
monitoring. Dr. Behrman joined the FDA in 1989 and has held a number
of positions in the Center for Drug Evaluation and Research, including
medical reviewer and team leader in the Division of Antiviral Drug Prod-
ucts and deputy director of the Office of Medical Policy. Dr. Behrman is a
board-certified internist and infectious disease subspecialist and a fellow of
the American College of Physicians. She received her A.B. in mathematics
from Washington University, her M.D. from Mt. Sinai School of Medicine,
and her M.P.H. from the Johns Hopkins School of Hygiene and Public
Health.
Jesse A. Berlin, Sc.D., received his doctorate in biostatistics from the Har-
vard School of Public Health in 1988. In 1989 he joined the faculty at the
University of Pennsylvania, in a unit that became the Center for Clinical
Epidemiology and Biostatistics, under the direction of Dr. Brian Strom. Dr.
Berlin spent several years as director of biostatistics for the University of
Pennsylvania Cancer Center, followed by assuming the role of faculty direc-
tor of the Biostatistics and Epidemiology Consulting Center. At the end of
the summer of 2004, Dr. Berlin left Penn to join Johnson & Johnson Phar-
maceutical Research and Development, where he is currently vice president
of pharmaco-epidemiology. He has authored or coauthored over 220 pub-
lications in a wide variety of clinical and methodological areas. Dr. Berlin
has a great deal of experience in both the application of meta-analysis and
the study of meta-analytic methods as applied to both randomized trials
and epidemiology. He has served as a consultant on meta-analysis for the
Australian government, and has served on two Institute of Medicine (IOM)
OCR for page 551
APPENDIX G
committees examining the association between exposure to chemicals con-
tained in Agent Orange and risk of a wide variety of diseases.
Eugene H. Blackstone, M.D., is full-time head of clinical investigations at
the Cleveland Clinic Heart and Vascular Institute (HVI) and a staff member
at the Department of Thoracic and Cardiovascular Surgery, Quantitative
Health Sciences, and Transplant Center. He is also a member of the HVI
Executive Committee. In addition to generating new knowledge from clini-
cal experiences, his specialty interests include novel mathematical models
for analyzing time-related and longitudinal clinical outcomes, digital signal
processing, mathematical models of the circulatory system, and seman-
tic knowledgebase/database technology. He received undergraduate and
medical degrees from the University of Chicago, followed by a research
fellowship in mathematics, computer science, and statistics. He completed
his medical internship at the University of Alabama at Birmingham (UAB)
and served for 3 years as chief of the cardiovascular medicine branch at the
U.S. Army Aeromedical Research Laboratory. He joined the UAB cardiac
surgery faculty in 1972 as a full-time physician investigator and became the
Cardiovascular Surgical Research Professor of Surgery in 1980. A major
culmination of Dr. Blackstone’s activities is the textbook Cardiac Surgery,
now in its third edition. He joined the Cleveland Clinic in 1997 to head
a multidisciplinary clinical research team focused on ischemic and valvar
heart diseases, heart rhythm disturbances, heart failure, and benign and
malignant diseases of the esophagus and lungs. He also leads a team of
computer scientists in developing a novel semantic approach to data stor-
age and use. Since 1987, Dr. Blackstone has been associate editor of the
Journal of Thoracic and Cardiovascular Surgery. He has published over
450 articles and has received numerous awards, including a Distinguished
Service Award from the University of Chicago in 1998 and the Maria and
Sam Miller Professional Excellence Award for Scientific Achievement in
Clinical Research in 2003. He is professor of surgery at the University of
Toronto and at the Cleveland Clinic Lerner College of Medicine of Case
Western Reserve University.
Carmella A. Bocchino, R.N., M.B.A., is a leading authority on identifying
and promoting medical management strategies that advance public health
goals and improve the overall quality of health care. As executive vice presi-
dent of clinical affairs and strategic planning at America’s Health Insurance
Plans, Ms. Bocchino works with the executives of member organizations to
develop innovative patient-centered medical management tools and clinical
delivery models, foster private–public partnerships and advance an inter-
connected health care system. A registered professional nurse and former
hospital administrator, Ms. Bocchino’s clinical and public policy expertise
OCR for page 552
2 LEARNING WHAT WORKS
has been widely recognized by national and state lawmakers, policy mak-
ers, patient advocacy groups, employers, and throughout the health care
community. She has been appointed to numerous private, state, and federal
healthcare advisory committees, including the IOM Study of the Medicare
End-Stage Renal Disease program, advisor to the RAND Health Sciences
Program for the capitation study for the end-stage renal disease project,
the Advisory Committee for Quality Improvement Standards for Managed
Care, the planning committee establishing the National Quality Forum, and
the Robert Wood Johnson Foundation (RWJF) Office of the National Coor-
dinator for Health Information Technology Health Information Technology
Adoption Initiative Expert Consensus Panel. She currently serves on the
RWJF National Advisory Committee of Project Health Design: Rethinking
the Power and Potential of Personal Health Records. Ms. Bocchino received
her M.B.A. from Rutgers University, Graduate School of Management
(Newark, NJ). She also has an undergraduate degree in human resources
management from Upsala College and a nursing degree from Mountainside
Hospital School of Nursing. Prior to her positions in health policy, Ms.
Bocchino held administrative and clinical positions in critical care medicine
and renal replacement therapy.
Kathleen A. Buto, M.P.A., is vice president for health policy, government
affairs, at Johnson & Johnson. She has responsibility for providing policy
analysis and developing positions on a wide range of issues, including
the Medicare drug benefit, government reimbursement, coverage of new
technologies, and regulatory requirements. In addition to reviewing how
federal, state, and international government policies affect Johnson & John-
son products and customers, she is responsible for helping identify areas of
opportunity for Johnson & Johnson to take leadership in shaping health-
care policy. Prior to joining Johnson & Johnson, Ms. Buto was a senior
health advisor at the Congressional Budget Office, helping to develop the
cost models for the Medicare drug benefit. Before that, she spent more than
18 years in senior positions at the Health Care Financing Administration,
including deputy director of the Center for Health Plans and Providers,
and associate administrator for policy. In these positions, she headed the
policy, reimbursement, research, and coverage functions for the agency, as
well as managing Medicare’s fee-for-service and managed care operations.
Ms. Buto received her B.A. from Douglass College and her M.P.A. from
Harvard University.
Timothy S. Carey, M.D., M.P.H., was named director of the Cecil G. Sheps
Center for Health Services Research in October 2000. A Sheps Center
fellow and University of North Carolina (UNC) at Chapel Hill faculty
member since 1986, Dr. Carey is a physician and health services researcher
OCR for page 553
APPENDIX G
with interests related to evidence-based medicine, access to care, health
disparities, and medical outcomes. Several of his current research projects
examine technology assessment, including the benefits and disadvantages of
tube feedings in the frail elderly. He has also conducted a number of studies
to examine the outcomes of care for low back pain, and he is codirector of
the joint Research Triangle Institute/UNC Evidence-Based Practice Center
examining the strength of the literature on a variety of medical and health
policy topics. Dr. Carey is a Sarah Graham Kenan Professor in the depart-
ments of medicine and social medicine at UNC at Chapel Hill and was chief
of the Division of General Medicine and Clinical Epidemiology at the UNC
at Chapel Hill School of Medicine from 1991 to 2000. He is a frequent
federal reviewer and has served as a member of the IOM’s Monitoring
Panel on Access to Care. He teaches at both the UNC schools of medicine
and public health.
Benjamin K. Chu, M.D., M.P.H., is the Southern California regional presi-
dent for Kaiser Foundation Health Plan and Hospitals, the nation’s largest
integrated health system, serving 8.7 million members in 10 states. His
region is responsible for the care of 3.3 million patients. Before joining
Kaiser, Dr. Chu was the president of the New York City Health and Hos-
pitals Corporation, the largest municipal hospital system in the country,
serving 1.3 million New York City residents with 11 hospitals, 5 skilled
nursing facilities, and scores of outpatient facilities. Dr. Chu is an internist
by training and has served as an associate dean and vice president for
clinical affairs for the New York University (NYU) School of Medicine
and as a senior associate dean for the Columbia College of Physicians
and Surgeons. His experience with graduate medical education on the
policy level, as the accountable executive for residency training programs
in a large city hospital, and his experience working directly with medi-
cal students and residents—combined with his work with health systems’
transformation—give him a unique perspective on the changes that will
be needed in workforce training to adapt to a patient-centered, evidenced-
based healthcare system.
Don E. Detmer, M.D., M.A., is president and chief executive officer of the
American Medical Informatics Association. He is also professor of medical
education in the Department of Public Health Sciences at the University of
Virginia, and visiting professor at the Centre for Health Informatics and
Multiprofessional Education, University College of London. Dr. Detmer
is a member of the IOM as well as a lifetime associate of the National
Academies. He is a fellow of American Association for the Advancement
of Science (AAAS) as well as the American Colleges of Medical Informat-
ics, Sports Medicine, and Surgeons. In addition to co-chairing the Blue
OCR for page 554
LEARNING WHAT WORKS
Ridge Academic Health Group, he chairs the board of MedBiquitous. He
is treasurer of the Council of Medical Specialty Societies. Dr. Detmer is past
chairman of the Board on Health Care Services of the IOM, the National
Committee on Vital and Health Statistics, and the Board of Regents of the
National Library of Medicine. He was a commissioner on the President’s
recent Commission on Systemic Interoperability. He chaired the 1991 IOM
study, The Computer-Based Patient Record, and coedited the 1997 version
of the same report. He was a member of the committee that developed the
IOM reports To Error Is Human and Crossing the Quality Chasm. From
1999 to 2003 he was the Dennis Gillings Professor of Health Management
at Cambridge University and is a lifetime member of Clare Hall College,
Cambridge. His education includes a M.D. from the University of Kansas
with subsequent training at the National Institutes of Health, the Johns
Hopkins Hospital, Duke University Medical Center, the IOM, and Harvard
Business School. His M.A. is from the University of Cambridge.
Carol C. Diamond, M.D., M.P.H., is the managing director of the Health
Program of the Markle Foundation and chairs Connecting for Health, a
public–private collaborative working to realize the full potential of informa-
tion technology in health and health care in the United States. Connecting
for Health engages more than 100 diverse organizations and institutions in
an approach rooted in core values, including achieving medical excellence,
fostering patient participation, and protecting personal privacy. Before
joining the Markle Foundation, Dr. Diamond was president of U.S. Qual-
ity Algorithms (USQA), Aetna U.S. Healthcare’s performance measurement
affiliate. Prior to joining USQA, Dr. Diamond was a consultant for John-
son & Johnson Health Care Systems and the RWJF. Dr. Diamond sits on
the American Academy of Family Physicians Public Advisory Board, the
Electronic Health Record Safety Institute Advisory Board of the Geisinger
Center for Health Research, and is a member of the IPRO Advisory Board
for the Centers for Medicare & Medicaid Services (CMS) Doctor’s Office
Quality-Information Technology project in New York. Dr. Diamond earned
her dual B.A./M.D. at the Medical School of SUNY at Brooklyn and her
M.P.H. at the University of Medicine and Dentistry of New Jersey of Rut-
gers University.
T. Bruce Ferguson, Jr., M.D., is chairman of the Department of Cardiovas-
cular Sciences at the East Carolina Heart Institute and the Brody School
of Medicine at East Carolina University. He is a board-certified cardiotho-
racic surgeon who specializes in adult cardiothoracic surgery. He came to
North Carolina from Louisiana, where he was Chief of Cardiac Surgery at
Louisiana State University Health Sciences Center in New Orleans prior to
Hurricane Katrina. While in Louisiana, he received funding from the Trans-
OCR for page 555
APPENDIX G
forming Healthcare Quality through Information Technology program of
the Agency for Healthcare Research and Quality (AHRQ) to begin develop-
ment of a longitudinal cardiovascular information system for the statewide
Charity Hospital System population. He served for 6 years as the inaugural
chair of the Society of Thoracic Surgeons Council on Quality, Research,
and Patient Safety, which oversees all aspects of the society’s national data-
base efforts, in collaboration with the Duke Clinical Research Institute.
He was principal investigator on the society’s two clinical trials in quality
improvement from 1999 through 2007, funded by AHRQ; this effort also
led to the creation of the National Consortium of Clinical Databases. He
is currently coprincipal investigator on the combined Duke–East Carolina
University Clinical Site for the National Heart, Lung, and Blood Institute
Cardiac Surgical Network, and he is principal investigator for the Clinical
Research Skills Development Core. He is a fellow of the American Heart
Association and is a member of the Quality Strategic Directions Commit-
tee and the Surgical Council for the American College of Cardiology. He
received his degree in chemistry from Williams College, and received his
M.D. degree from Washington University in St. Louis. He completed his
training in general surgery and cardiothoracic surgery at Duke University
Medical Center.
Daniel E. Ford, M.D., M.P.H., is a graduate of Cornell University and
SUNY at Buffalo School of Medicine. He completed his internal medicine
residency at the Johns Hopkins Hospital and received an M.P.H. from the
Johns Hopkins School of Public Health. From 1985 to 1988 he was a fellow
at the National Institute of Mental Health. He currently is the David M.
Levine Professor of Medicine and Psychiatry at Johns Hopkins School of
Medicine. Until he was appointed the vice dean for clinical investigation in
2005, he had been the director of the University Health Service since 1992.
In 2007 he was appointed as director of the Johns Hopkins Institute for
Clinical and Translational Research. Dr. Ford is one of the investigators that
first documented the link between depression and subsequent heart disease.
He has authored over 140 articles and book chapters. He has worked for
many years on improving the quality of care for mental disorders in pri-
mary care and general medical settings. He was one of the coleaders for the
Institute for Health Care Improvement Bureau of Primary Care Depression
Collaborative. In addition, he currently is leading the evaluation for the
RWJF Depression in Primary Care Program.
Mark E. Frisse, M.D., M.B.A., M.Sc., is a professor of biomedical informat-
ics at Vanderbilt University. Working through the office of the Governor of
the State of Tennessee he directs a federal- and state-sponsored health infor-
mation exchange in the greater Memphis area with over 2 million records
OCR for page 556
LEARNING WHAT WORKS
covering the care of over 1 million individuals. He is active in a number
of Markle Foundation efforts and served as a co-chair of the Connecting
for Health Common Framework policy group developing model data-
sharing agreements. He is a participant in the RWJF Project HealthDesign
personal health records initiative. Dr. Frisse has worked in the academic
sector, in consulting, and in pharmacy benefits management. He has served
as a board member of the American Medical Informatics Association, the
eHealth Initiative, the State of Tennessee Governor’s eHealth Task Force,
and SureScripts, LLC.
Jean Paul Gagnon, Ph.D., is director of public policy at sanofi-aventis in
Bridgewater, New Jersey. He received a B.S. in pharmacy and a M.S. in
pharmacy administration from the University of Connecticut and a Ph.D.
in pharmacy administration from Ohio State University. He is a former
professor and division head of pharmacy administration in the School of
Pharmacy at UNC and has worked for sanofi-aventis for 17 years. He has
written over 60 articles in peer-reviewed journals and has made presenta-
tions on a variety of issues, including Medicare, Part D, evidence-based
medicine, and the effect of federal policy on the pharmaceutical industry
and pharmacy practice. In 2002 he received the American Public Health
Association Hugo H. Schaefer Award for outstanding volunteer contribu-
tions to the profession of pharmacy. From 1981 to 1982, he was an RWJF
Health Policy Fellow in Washington, DC, and worked as a committee staff
person on Energy and Commerce’s Subcommittee on Health. He was chair-
man of the Health Outcomes Committee of the Pharmaceutical Research
Manufacturers of America from 1997 until 2001, president of the American
Association of Colleges of Pharmacy for the 1985–1986 year, served as
treasurer and a board of trustee member of the American Pharmaceutical
Association from 1991 until 1997, served as president of the International
Association of Pharmaco-economics and Outcomes Research from 1996
until 1997 and was their treasurer from 1998 until 2004, and was a mem-
ber of the board of trustees and treasurer for the U.S. Pharmacopeia from
1995 until 2005.
Stuart Guterman, Ph.D., has been senior program director for the Com-
monwealth Fund’s Program on Medicare’s Future since May 2005. He
is responsible for the fund’s research agenda on Medicare issues. He was
director of the Office of Research, Development, and Information at CMS
from 2002 to 2005, where he was responsible for research on Medicare
and Medicaid issues, evaluation of Medicare and Medicaid programs,
and developing, implementing, and conducting Medicare demonstrations.
Prior to that Dr. Guterman was a senior analyst at the Congressional
Budget Office, a principal research associate in the Health Policy Cen-
OCR for page 557
APPENDIX G
ter at the Urban Institute, and deputy director of the Medicare Payment
Advisory Commission (MedPAC) (and its predecessor, the Prospective Pay-
ment Assessment Commission) from 1988 through 1999. Previously, Dr.
Guterman was chief of institutional studies in the Health Care Financing
Administration’s Office of Research.
Bruce H. Hamory, M.D., is executive vice president and chief medical
officer emeritus for Geisinger Health System. As such, he oversees the
research activities of the Weis Center for Research and the Hood Center for
Health Research as well as the medical education programs for the health
system. As Geisinger’s system chief medical officer from 1997 to 2008, he
was responsible for guiding the activities of a 740-member multispecialty
physician group practice in 40 locations serving 41 counties and the 3
Geisinger hospitals. These activities included compensation, quality and
performance improvement, credentialing, research, and education. As one
of the executive leaders for the system, he was involved directly in clinical
operations, capital planning, and other issues for the clinic and the health
system. Dr. Hamory is on the board of directors for the American Medical
Group Association and serves on several national committees and panels
concerned with improving the quality of medical care.
W. David Helms, Ph.D., is president and chief executive officer of
AcademyHealth in Washington, DC, the professional society for health
services researchers, policy analysts, and practitioners and a leading, non-
partisan resource for the best in health research and policy. Its programs
are dedicated to stimulating the development, understanding, and use of
the best available health services research and health policy information by
public and private decision makers. In addition to leading AcademyHealth,
Dr. Helms serves as president and chief executive officer of the Coalition of
Health Services, AcademyHealth’s advocacy arm. The coalition provides a
unified voice for enhanced federal funding of health services research and
health data to inform health policy and practice.
William R. Hersh, M.D., is professor and chair of the Department of Medi-
cal Informatics and Clinical Epidemiology in the School of Medicine at
Oregon Health and Science University (OHSU) in Portland, Oregon. He
is a leader and innovator in biomedical informatics both in education and
research. Dr. Hersh has performed research in biomedical informatics in a
number of areas. A current major interest of his is the health information
technology (HIT) workforce, focusing on the personnel, their skills, and
their training for implementing, innovating, and evaluating systems. Dr.
Hersh is also active in clinical and translational research informatics. He
serves as director of the biomedical informatics program of the Oregon
OCR for page 558
LEARNING WHAT WORKS
Clinical and Translational Research Institute and is chair of the National
Informatics Steering Committee of the Clinical and Translational Science
Awards program of the National Institutes of Health (NIH). His origi-
nal focus of research was in the area of information retrieval, where he
has authored over 100 scientific papers as well as the book, Information
Retrieval: A Health & Biomedical Perspective. In education, Dr. Hersh
serves as director of informatics educational programs at OHSU, where he
has led the development of educational programs at the certificate, master’s,
and doctoral levels. He also initiated OHSU’s efforts into distance learning
for biomedical informatics. Most recently, he teamed up with the American
Medical Informatics Association to launch the 10x10 program that aims to
train 10,000 clinicians and others in informatics by the year 2010.
David H. Hickam, M.D., M.P.H., holds the rank of professor in the Depart-
ment of Medicine at OHSU. He is a health services researcher and is
director of the John M. Eisenberg Center at OHSU. He also serves as
coprincipal investigator of the Health Services Research and Development
Service Research Enhancement Award Program at the Portland Department
of Veteran Affairs Medical Center. His research interests include clinical
decision making, practice variation in both primary care and specialty set-
tings, and patients’ perceptions of their health care. The Eisenberg Center
is part of the Effective Health Care Program of AHRQ and is charged
with developing practical tools to assist consumers, clinicians, and policy
makers in using clinical evidence for their decision making. This work
uses a rigorous method of evidence translation and a product development
process based on obtaining the perspectives of end users through qualita-
tive research methods. Dr. Hickam directs an interdisciplinary team and
has performed evidence translations on 15 clinical topics commissioned
by AHRQ. Dr. Hickam was formerly a member of the editorial board of
Medical Decision Making.
Erin Holve, Ph.D., M.P.H., M.P.P., is a senior manager at AcademyHealth.
Dr. Holve heads AcademyHealth’s work in professional development and
continuing education, with a specific focus on analytic methods used in
health services research. Prior to joining AcademyHealth, she worked as a
consultant to AcademyHealth, creating the online methods resource, and
she was part of the initial team that drafted core competencies for doctoral
training in health services research. Previously, she worked for the Henry
J. Kaiser Family Foundation as a senior policy analyst studying employer-
sponsored health insurance and developed the online resource State Health
Facts Online. She has also worked for the Department of Health and
Human Services (HHS) on the Health Insurance Portability and Account-
ability Act and has consulted for local, regional, and national health policy
organizations. She holds a Ph.D. in health services research from the Bloom-
OCR for page 559
9
APPENDIX G
berg School of Public Health at Johns Hopkins University and master’s
degrees in public health and public policy from the UC at Berkeley.
Richard A. Justman, M.D., is national medical director of UnitedHealth-
care, a national health service delivery company. He works in the clinical
advancement division. Dr. Justman is accountable for medical technology
assessment, clinical support of pharmacy programs, and clinical support of
benefit administration. He has been with UnitedHealthcare since 1993. He
received his bachelor’s degree from Cornell University and his M.D. degree
from SUNY at Buffalo. He is board certified in pediatrics and received his
postgraduate training at the University of Chicago Hospitals and Clinics
and the Johns Hopkins Hospital. Dr. Justman practiced pediatrics in Min-
neapolis, Minnesota, for 15 years before joining UnitedHealthcare. He has
served on the IOM Forum on Drug Discovery, Development, and Transla-
tion; the IOM Committee to Identify Highly Effective Clinical Services; the
American Medical Association (AMA) Current Procedural Terminology
codes-5 Project; the AMA Initiative to Transform Medical Education; and
an expert panel developing an evidence report on diabetes education for
children with type I diabetes, commissioned by AHRQ. Dr. Justman served
on the AHRQ Stakeholders Panel for 2008 and 2009. He speaks frequently
to external audiences on the use of clinical evidence to determine the safety
and effectiveness of new and emerging medical treatments.
Douglas B. Kamerow, M.D., M.P.H., is a chief scientist at RTI Interna-
tional, a not-for-profit research company based in Research Triangle Park,
North Carolina, where he leads research and evaluation projects in the
areas of health policy, childhood obesity, preventive medicine, and evidence-
based practice. Dr. Kamerow was formerly director of several key programs
at AHRQ, including the Center for Practice and Technology Assessment
and the Office of the Forum for Quality and Effectiveness in Health Care.
He retired from the Public Health Service Commissioned Corps in 2001
with the rank of assistant surgeon general. He is a family physician and
preventive medicine specialist with clinical, public health, and epidemio-
logic training. Dr. Kamerow is presently associate editor of BMJ (formerly
British Medical Journal), for whom he writes a regular column on health
policy issues; he previously served for 2 years as the BMJ’s U.S. editor. He
is also a healthcare commentator for All Things Considered on National
Public Radio. Finally, Dr. Kamerow is professor of clinical family medicine
at Georgetown University in Washington, DC, where he teaches medical
students and family medicine residents.
Mark B. McClellan, M.D., Ph.D., became the director of the Engelberg
Center for Healthcare Reform at the Brookings Institution in July 2007.
The center studies ways to provide practical solutions for access, quality,
OCR for page 560
0 LEARNING WHAT WORKS
and financing challenges facing the U.S. healthcare system. In addition, Dr.
McClellan is the Leonard D. Schaeffer Chair in Health Policy Studies. Dr.
McClellan has a highly distinguished record in public service and in aca-
demic research. He is the former administrator for CMS (2004 to 2006)
and the former commissioner of the FDA (2002 to 2004). He also served
as a member of the President’s Council of Economic Advisers and senior
director for healthcare policy at the White House (2001 to 2002). In these
positions, he developed and implemented major reforms in health policy.
Dr. McClellan was also an associate professor of economics and associate
professor of medicine (with tenure) at Stanford University, from which he
was on leave during his government service. He directed Stanford’s Program
on Health Outcomes Research and was also associate editor of the Jour-
nal of Health Economics and coprincipal investigator of the Health and
Retirement Study, a longitudinal study of the health and economic status
of older Americans. His academic research has been concerned with the
effectiveness of medical treatments in improving health, the economic and
policy factors influencing medical treatment decisions and health outcomes,
the impact of new technologies on public health and medical expenditures,
and the relationship between health status and economic well-being. Dr.
McClellan is a member of the IOM of the National Academy of Sciences
and a research associate of the National Bureau of Economic Research. A
graduate of the University of Texas at Austin, Dr. McClellan earned his
M.P.A. from Harvard’s Kennedy School of Government in 1991, his M.D.
from the Harvard–Massachusetts Institute of Technology (MIT) Division
of Health Sciences and Technology in 1992, and his Ph.D. in economics
from MIT in 1993.
J. Michael McGinnis, M.D., M.P.P., is a long-time contributor to national
and international health policy leadership, now senior scholar at the IOM,
and executive director of the IOM Roundtable on Evidence-Based Medi-
cine. He is also an elected member of the IOM. He previously was senior
vice president at the RWJF, and, unusual for political posts, held continu-
ous appointment through the Carter, Reagan, Bush, and Clinton admin-
istrations, with responsibility for coordinating activities and policies in
disease prevention and health promotion. Programs and policies created
and launched at his initiative include the Healthy People process for set-
ting national health objectives, the U.S. Preventive Services Task Force,
the Dietary Guidelines for Americans (with the U.S. Department of Agri-
culture), the Ten Essential Services of Public Health, the RWJF Health
and Society Scholars Program, the RWJF Young Epidemiology Scholars
Program, and the RWJF Active Living family of programs. Internationally,
he chaired the World Bank/European Commission Task Force on postwar
OCR for page 561
APPENDIX G
reconstruction of the health sector in Bosnia and worked both as field
epidemiologist and state coordinator for the World Health Organization’s
successful smallpox eradication program in India.
Robert H. Miller, Ph.D., is professor of health economics in residence at the
Institute for Health and Aging and in the Department of Social and Behav-
ioral Sciences at UC at San Francisco. He received his doctorate in econom-
ics from the University of Michigan in 1987 and has been a faculty member
since 1989. Dr. Miller conducts research on the economics of HIT and
organizational change in ambulatory care settings, including health policy-
oriented research on electronic health records (EHRs), patient–provider
e-health capabilities, and community-wide electronic clinical data exchange.
Dr. Miller is especially interested in EHR use for quality improvement in
solo/small groups and community health centers. Dr. Miller is a member
of the Joint Commission’s HIT Advisory Panel and Lemetra’s Quality
Improvement Advisory Committee, was a member of the Connecting for
Health Working Group on the economics of HIT, and is serving and has
served as a member on HIT expert panels. Dr. Miller also has published on
such topics as health maintenance organization (HMO) versus non-HMO
plan performance, efforts by large medical groups to reduce medical inju-
ries, the effects of managed care on physician practice change, as well as on
acute and long-term care services for chronically impaired elders.
Nancy H. Nielsen, M.D., Ph.D., is an internist from Buffalo, New York,
and current president of the AMA. She was elected speaker of the AMA
House of Delegates in June 2003 and reelected in 2005. She is a delegate
from New York and previously served two terms on the AMA Council on
Scientific Affairs. Dr. Nielsen has also served as a member on the National
Patient Safety Foundation Board of Directors, the Commission for the Pre-
vention of Youth Violence, the Task Force on Quality and Patient Safety,
the HHS Secretary’s Advisory Committee on Regulatory Reform, and as
the AMA representative to the National Quality Forum, Physicians Con-
sortium for Performance Improvement, the Hospital Quality Alliance, and
the Ambulatory Care Quality Alliance. She holds a Ph.D. in microbiology
and received her M.D. from the SUNY School of Medicine and Biomedical
Sciences in Buffalo, where she is clinical professor of medicine and senior
associate dean for medical education. She has served as a trustee of SUNY
and as a member of the board of directors of Kaleida Health—a five-
hospital system in western New York. She is currently associate medical
director for quality and interim chief medical officer at Independent Health
Association, a major health insurer in New York.
OCR for page 562
2 LEARNING WHAT WORKS
Parashar B. Patel, M.P.A., joined Boston Scientific Corporation as vice
president of health economics and reimbursement for the Healthcare Strate-
gies and Programs group in 2003. Dr. Patel is responsible for the company’s
corporate and site health economics and reimbursement functions, chiefly
focusing on the development and implementation of global strategic, reim-
bursement, and legislative initiatives. He is also closely involved in health
economics analysis and outcomes research for the company. Prior to join-
ing, Dr. Patel was deputy director of the Hospital and Ambulatory Policy
Group in the Center for Medicare Management at CMS. The group was
responsible for Medicare payment policy for a wide range of acute and
ambulatory care services, including inpatient and outpatient hospital ser-
vices and physician services. He has extensive experience in healthcare
financing policy through his work with the American Association of Health
Plans, the Office of (then) Senate Majority Leader George J. Mitchell,
the U.S. Office of Management and Budget, and Connecticut’s Medicaid
agency. He holds a B.A. in political science and a master of public affairs
from the University of Connecticut.
Steve E. Phurrough, M.D., M.P.A., C.P.E., is the director of the coverage
and analysis group for CMS. Using evidence-based medicine principles, he
assists in developing national policy on the appropriate devices, diagnos-
tics, and procedures that should be provided by the Medicare program. Dr.
Phurrough joined CMS in 2001 as the director of the division of medical
and surgical services in the coverage and analysis group after completing
a long and distinguished career in the U.S. Army. In addition to being a
practicing family practitioner, his military career also included manag-
ing Department of Defense regional healthcare delivery systems, creating
national and international healthcare policy for the U.S. Army, and devel-
oping practice guidelines. Dr. Phurrough received his M.D. from the UAB
and an M.P.A. from the University of Colorado in Colorado Springs. He is
board certified by the American Board of Family Practice and is a certified
physician executive.
William Z. Potter, M.D., Ph.D., earned his degrees at Indiana University,
after which he functioned in positions of increasing responsibility and
seniority over the next 25 years at the NIH focused on translational neuro-
science. While at the NIH, Dr. Potter was widely published and appointed
to many societies, committees, and boards, a role that enabled him to
develop a wide reputation as an expert in psychopharmacological sciences
and championing the development of novel treatments for central nervous
system (CNS) disorders. Dr. Potter left the NIH in 1996 to accept a posi-
tion as executive director and research fellow at Lilly Research Laborato-
OCR for page 563
APPENDIX G
ries, specializing in the neuroscience therapeutic area and in 2004 joined
Merck Research Laboratories as vice president of clinical neuroscience,
then the newly created position of translational neuroscience in 2006. His
experience at Lilly and Merck in identifying, expanding, and developing
methods of evaluating CNS effects of compounds in human brain cover
state-of-the-art approaches across multiple modalities. These include brain
imaging and cerebrospinal fluid proteomics (plus metabolomics), as well as
the development of more sensitive clinical, psychophysiological, and perfor-
mance measures that allow a range of novel targets to be tested in a manner
that actually addresses the underlying hypotheses. Dr. Potter has become a
widely recognized champion for the position that more disciplined hypoth-
esis testing of targets in humans is the best near-term approach to moving
CNS drug development forward.
John W. Rowe, M.D., is currently a professor in the Department of Health
Policy and Management at the Columbia University Mailman School of
Public Health. From 2000 until his retirement in late 2006, Dr. Rowe
served as chairman and chief executive officer of Aetna, Inc., one of the
nation’s leading health care and related benefits organizations. Before his
tenure at Aetna, from 1998 to 2000, Dr. Rowe served as president and chief
executive officer of Mount Sinai–NYU Health, one of the nation’s largest
academic healthcare organizations. From 1988 to 1998, prior to the Mount
Sinai–NYU Health merger, Dr. Rowe was president of the Mount Sinai
Hospital and the Mount Sinai School of Medicine in New York City. Before
joining Mount Sinai, he was a professor of medicine and the founding
director of the Division on Aging at the Harvard Medical School, as well
as chief of gerontology at Boston’s Beth Israel Hospital. He has authored
over 200 scientific publications, mostly on the physiology of the aging
process, including a leading textbook of geriatric medicine, in addition
to more recent publications on healthcare policy. Dr. Rowe has received
many honors and awards for his research and health policy efforts regard-
ing care of elderly people. He was director of the MacArthur Foundation
Research Network on Successful Aging and is coauthor, with Dr. Robert
Kahn, of Successful Aging (Pantheon, 1998). Dr. Rowe currently leads the
MacArthur Foundation’s Initiative on an Aging Society. He was elected a
member of the IOM and a fellow of the American Academy of Arts and
Sciences. In addition, Dr. Rowe is a former member of MedPAC. He is also
chairman of the board of trustees at the University of Connecticut and the
Marine Biological Laboratory in Woods Hole, Massachusetts.
Richard N. Shiffman, M.D., M.C.I.S., is professor of pediatrics and asso-
ciate director of the Center for Medical Informatics at Yale School of
Medicine. Dr. Shiffman is a fellow of the American College of Medical
OCR for page 564
LEARNING WHAT WORKS
Informatics and the American Academy of Pediatrics (AAP). Dr. Shiffman
serves on the AAP’s Partners for Policy Implementation. He has served on
several guideline development panels for national professional societies and
on the AAP’s Steering Committee on Quality Improvement and Manage-
ment. In addition, Dr. Shiffman leads the GuideLines Into DEcision Sup-
port Project—an AHRQ-sponsored collaboration that is demonstrating
transparent, systematic, and replicable processes for transforming guideline
knowledge into computer-mediated decision support.
Jean R. Slutsky, P.A., M.S.P.H., has directed the Center for Outcomes
and Evidence (COE) at AHRQ since June 2003. Prior to Ms. Slutsky’s
appointment as director of COE, she served as acting director of the Cen-
ter for Practice and Technology Assessment at AHRQ. Most recently, Ms.
Slutsky has implemented a comparative effectiveness research program that
includes evidence synthesis, evidence generation, and evidence communica-
tion. The Effective Health Care Program is authorized under Section 1013
of the Medicare Prescription Drug, Improvement, and Modernization Act.
Ms. Slutsky oversees the Evidence-Based Practice Center Program; Technol-
ogy Assessment Program; extramural and intramural research portfolios
concerning translating research into practice, outcomes, and effectiveness
research, including pharmaceutical outcomes, and cost-effectiveness anal-
yses; and the National Guideline, Quality Measures, and QualityTools
Clearinghouses. She is a vice chair of the Guidelines International Network
and a member of the editorial board of Implementation Science. Prior to
becoming acting director of the Center for Practice and Technology Assess-
ment, Ms. Slutsky served as project director of the U.S. Preventive Services
Task Force, an internationally recognized panel of experts who make evi-
dence-based recommendations on clinical preventive services. Ms. Slutsky
received her Bachelor of Science degree at the University of Iowa, a Master’s
of Science in Public Health (health policy and administration) from UNC
at Chapel Hill, and trained as a physician assistant at the University of
Southern California.
Donald M. Steinwachs, Ph.D., is a professor in the Department of Health
Policy and Management and director of the Health Services Research and
Development Center at the Johns Hopkins University Bloomberg School
of Public Health. Dr. Steinwachs’s research seeks to identify opportunities
to improve quality of health care and patient outcomes and, when fea-
sible, evaluate promising quality improvement interventions. His previous
research includes studies of medical effectiveness and patient outcomes for
individuals with specific medical (e.g., asthma), surgical (e.g., cataract sur-
gery), and psychiatric (e.g., schizophrenia) conditions. Dr. Steinwachs has
contributed to the literature on the impact of managed care and payments
OCR for page 565
APPENDIX G
systems on access to care, quality, utilization, and cost. He was a codevel-
oper of the widely used adjusted clinical groups case mix adjustment. He
has developed methods for measuring provider continuity, needs and unmet
needs for care, and measures of the timeliness of care. He has a particular
interest in the role of routine management information systems (MIS) as
source of data for evaluating the effectiveness and cost of health care. This
includes work on the integration of outcomes management systems with
existing MIS in managed care settings. He is a member of the IOM and
its Board of Health Care Services. A member of the National Committee
on Vital and Health Statistics since 2002, he chairs the Subcommittee on
Populations and serves on the executive committee. He also serves on the
board of Mathematica Policy Research, Inc. Dr. Steinwachs holds a B.S. in
engineering mathematics and an M.S. in systems engineering from the Uni-
versity of Arizona and a Ph.D. in operations research from Johns Hopkins
University.
Robert J. Temple, M.D., is director of the Office of Medical Policy of the
FDA’s Center for Drug Evaluation and Research and is also acting director
of the Office of Drug Evaluation I (ODE-I). ODE-I is responsible for the
regulation of cardio-renal, neuropharmacologic and psychopharmacologic
drug products. The Office of Medical Policy is responsible for regulation
of promotion through the Division of Drug Marketing, Advertising, and
Communication and for assessing quality of clinical trials. Dr. Temple has
a long-standing interest in the design and conduct of clinical trials and
has written extensively on this subject, especially on the choice of control
groups in clinical trials, evaluation of active control trials, trials to evaluate
dose–response, and trials using “enrichment” designs.
Sean R. Tunis, M.D., M.Sc., is the founder and director of the Center
for Medical Technology Policy in San Francisco, where he works with
healthcare decision makers, experts, and stakeholders to improve the value
of clinical research on new and existing medical technologies. He con-
sults with a range of domestic and international healthcare organizations
on issues of comparative effectiveness, evidence-based medicine, clinical
research, and technology policy. Through September 2005, Dr. Tunis was
the director of the Office of Clinical Standards and Quality and chief medi-
cal officer at CMS. In this role, he had lead responsibility for clinical policy
and quality for the Medicare and Medicaid programs, which provide health
coverage to over 100 million U.S. citizens. Dr. Tunis supervised the devel-
opment of national coverage policies, quality standards for Medicare and
Medicaid providers, quality measurement and public reporting initiatives,
and the Quality Improvement Organization program. As chief medical
officer, Dr. Tunis served as the senior advisor to the CMS administrator
OCR for page 566
LEARNING WHAT WORKS
on clinical and scientific policy. He also co-chaired the CMS Council on
Technology and Innovation. Dr. Tunis joined CMS in 2000 as the director
of the Coverage and Analysis Group. Before joining CMS, Dr. Tunis was
a senior research scientist with the Technology Assessment Group, where
his focus was on the design and implementation of prospective compara-
tive effectiveness trials and clinical registries. Dr. Tunis also served as the
director of the health program at the Congressional Office of Technology
Assessment and as a health policy advisor to the U.S. Senate Committee
on Labor and Human Resources, where he participated in policy develop-
ment regarding pharmaceutical and device regulation. He received a B.S.
degree in biology and history of science from the Cornell University School
of Agriculture, and an M.D. and M.A. in health services research from the
Stanford University School of Medicine. Dr. Tunis did his residency training
at UC at Los Angeles and the University of Maryland in emergency medi-
cine and internal medicine. He is board certified in internal medicine and
holds adjunct faculty positions at Johns Hopkins and Stanford University
schools of medicine.
Steven A. Wartman, M.D., Ph.D., M.A.C.P., became the third president of
the Association of Academic Health Centers, based in Washington, DC, in
July 2005. Before assuming this position, he was the executive vice presi-
dent for academic and health affairs and dean of the school of medicine at
the University of Texas Health Science Center in San Antonio. Prior to his
tenure in San Antonio, Dr. Wartman held a number of other positions in
academic medicine, including the Edward Meilman Distinguished Chair-
man of Medicine and physician-in-chief at Long Island Jewish Medical
Center and professor of medicine at Albert Einstein College of Medicine.
Dr. Wartman began his career at Brown University and Rhode Island Hos-
pital where he founded the Division of General Internal Medicine and the
General Internal Medicine Residency Program. A graduate of Cornell Uni-
versity, Dr. Wartman received both his M.D. and Ph.D. degrees from Johns
Hopkins University. He was an RWJF Clinical Scholar at Johns Hopkins, a
Henry Luce Scholar in Indonesia, and is a past president of the Society of
General Internal Medicine. He is a board-certified internist, a sociologist,
and a master of the American College of Physicians. His publications and
interests lie in the areas of the structure and function of academic health
centers, healthcare delivery, health policy, medical education, and academic
leadership. He currently is a distinguished professor in the Department of
Medicine at Georgetown University and is an adjunct professor of medicine
at George Washington and Johns Hopkins universities.
Gail R. Wilensky, Ph.D., is an economist and a senior fellow at Project
HOPE who analyzes and develops policies relating to healthcare reform
OCR for page 567
APPENDIX G
and to ongoing changes in the healthcare environment. Dr. Wilensky is
a commissioner on the World Health Organization’s Commission on the
Social Determinants of Health and an elected member of the IOM of the
National Academies where she served two terms on its governing council, is
vice chair of the Maryland Health Care Commission, and serves as a trustee
of the Combined Benefits Fund of the United Mineworkers of America
and the National Opinion Research Center. She is an advisor to the RWJF
and the Commonwealth Fund, past chair of the board of directors of
AcademyHealth, and director on several corporate boards. From 1990 until
1992 she was administrator of the Health Care Financing Administration,
directing the Medicare and Medicaid programs. She also served as deputy
assistant to President George H.W. Bush for policy development, advis-
ing him on health and welfare issues from 1992 to 1993. From 1997 to
2001 she chaired MedPAC, which advises Congress on payment and other
issues relating to Medicare, and from 1995 to 1997 she chaired the Physi-
cian Payment Review Commission. From 2001 to 2003 she co-chaired the
President’s Task Force to Improve Health Care Delivery for Our Nation’s
Veterans, which covered health care for both veterans and military retir-
ees. In 2007 she was appointed to the President’s Commission on Care for
America’s Returning Wounded Warriors and also as the co-chair of the
Department of Defense task force on the future of military health care.
Dr. Wilensky testifies frequently before congressional committees, acts as
an advisor to members of Congress and other elected officials, and speaks
nationally and internationally before professional, business, and consumer
groups. She received a bachelor’s degree in psychology and a Ph.D. in eco-
nomics at the University of Michigan.
Mary E. Woolley, M.A., is the president of Research!America, the nation’s
largest not-for-profit alliance working to make research to improve health a
higher national priority. Research!America’s 500-plus organizational mem-
bers represent the voices of 125 million Americans. Ms. Woolley is an
elected member of the IOM and a fellow of the AAAS. She serves on several
boards and committees, including the IOM Health Sciences Policy Board,
the National Council for Johns Hopkins Nursing, and the board of over-
seers of the Harvard School of Public Health. She is a founding member of
the board of associates of the Whitehead Institute for Biomedical Research.
She has served as president of the Association of Independent Research
Institutes, as editor of the Journal of the Society of Research Administra-
tors, as a reviewer for the NIH and National Science Foundation, and as
a consultant to several research organizations. Ms. Woolley has a 25-year
editorial and publication history on science advocacy and research-related
topics. She is a sought-after speaker and is frequently interviewed by sci-
ence, news, and policy journalists.
OCR for page 568
